9 April 2019 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) is holding a public hearing on potential ways of regulating products containing cannabis and cannabis-derived compounds including cannabidiol (CBD).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.